🩸 World Sickle Cell Day · 19 June. View events → Call us: +64 21 231 8485

For Clinicians

Clinical resources, NZ referral pathways, emergency protocols, and partnership opportunities for those caring for whānau living with thalassaemia and sickle cell.

Partnership

You don't have to be a specialist to make a difference

Most GPs, ED clinicians, school nurses, and midwives see thalassaemia or sickle cell only rarely, but when they do, the patient's experience is shaped enormously by the encounter. We help clinicians at every level deliver care that's clinically right, culturally safe, and trusted.

  • Free clinical briefings and updates
  • NZ-specific referral pathways and protocols
  • CPD-accredited education sessions
  • Co-design partnerships for research and quality improvement
  • A clinical liaison contact for case discussions
Downloadable

Clinical briefings & pathway summaries

Quick-reference resources for clinicians at every point of care.

Emergency reference

Sickle cell pain crisis, first 30 minutes

The single most important thing to get right. Trust the patient on their pain level.

01

Triage as priority

Sickle cell pain crisis = high acuity. Don't wait. Analgesia within 30 minutes is the standard of care.

02

Believe the pain

SCD pain is severe and real. Many patients describe being routinely under-treated. Trust them on dose and previous regimen.

03

Hydrate & oxygenate

IV fluids (caution with overload), supplementary oxygen if SpO₂ low. Check for acute chest syndrome.

04

Reassess & escalate

Reassess pain at 30 mins. Call haematology if no relief. Admit threshold should be low.

For full protocol: download our 2-page ED quick reference above. For an urgent case discussion, our clinical advisor Dr Previn Dalal can be reached via our clinical liaison line.
Cultural safety

What culturally safe care looks like

Thalassaemia and sickle cell predominantly affect ethnic minority communities in Aotearoa. Culturally safe care isn't optional, it's clinical safety.

🗣️

Offer an interpreter

Don't rely on family members. Use professional interpreters for clinically significant conversations.

🙏

Respect health hierarchies

Many patients consult elders or whānau before decisions. Build in time. Don't rush.

⚖️

Be aware of bias

Sickle cell pain is one of the most under-treated conditions globally due to racial bias. Notice your own.

📿

Faith & care

Faith can shape decisions around blood transfusion, end-of-life care, family planning. Ask, don't assume.

🍽️

Diet & food

Dietary advice that ignores cultural foods isn't useful advice. Work with patients, not at them.

💬

Listen first

Many migrant patients have learned to stay quiet. Create space, silence isn't compliance.

NZ referral pathways

Who to refer where

Suspected case

Newly identified haemoglobinopathy

Order haemoglobin electrophoresis (or HPLC) plus full blood count and ferritin. Refer to adult or paediatric haematology at your nearest tertiary centre.

Carrier identified

Carrier (Minor / Trait)

Refer to NZ Genetic Health Service for counselling, especially if planning a family. Partner testing recommended. Connect family to TASCA NZ for plain-language explanation.

Antenatal

Antenatal screening positive

Same-day referral to maternal-foetal medicine. Partner testing urgent. NZ Genetic Health Service for counselling on prenatal diagnosis options.

Active disease

Established Beta Major or SCD

Lifelong haematology care. Establish a written individual care plan including emergency contacts. Consider mental health referral and TASCA NZ peer support.

Continuing education

CPD events & clinical briefings

We run regular CPD-accredited evening briefings for clinicians, online and in-person. Topics include emergency pain management, antenatal screening, gene therapy updates, and culturally safe care.

  • Quarterly online sessions (free, RACP/RNZCGP/MCNZ accredited)
  • Annual in-person symposium in Auckland
  • Bespoke briefings for your team, department, or DHB
  • Subscribe to our clinician newsletter for case studies and updates
View upcoming CPD →

Get in touch, clinical enquiries

For case discussions, in-service requests, referral pathway questions, or partnership enquiries.

Thank you, we've received your enquiry. Our clinical liaison will respond within 2 working days.

Caring for someone living with these conditions?

Connect with TASCA NZ. We'll back you up, and your patient will feel the difference.

Sources for this page

Clinical guidance and pathways draw from:

  1. NICE CG143 (sickle cell pain in hospital), 2012, reviewed 2020.
  2. British Society for Haematology guidelines (multiple, 2017-2024).
  3. Thalassaemia International Federation guidelines, 2021.
  4. Yawn BP et al. "Management of sickle cell disease: 2014 evidence-based report." JAMA, 2014; 312(10): 1033-48.
  5. Pharmaceutical Schedule (Pharmac NZ), 2024 listings.
  6. Te Whatu Ora regional referral pathways, 2024-2025.

View all references & sources →